For: | Shimizu Y. T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection. World J Gastroenterol 2012; 18(20): 2443-2451 [PMID: 22654441 DOI: 10.3748/wjg.v18.i20.2443] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i20/2443.htm |
Number | Citing Articles |
1 |
Kyoko Fuse, Yuichi Matsuyama, Masato Moriyama, Shukuko Miyakoshi, Yasuhiko Shibasaki, Jun Takizawa, Tatsuo Furukawa, Ichiro Fuse, Hiro Matsumura, Shigeharu Uchida, Yoshifumi Takahashi, Kenya Kamimura, Hiroyuki Abe, Takeshi Suda, Yutaka Aoyagi, Hirohito Sone, Masayoshi Masuko. Late Onset Post-Transfusion Hepatitis E Developing during Chemotherapy for Acute Promyelocytic Leukemia. Internal Medicine 2015; 54(6): 657 doi: 10.2169/internalmedicine.54.2332
|
2 |
Wang Hongfei, Zhao Yunyan, Yan Fei, Liu Hui. Evaluation of an artificial neural network to ascertain why there is a high incidence of hepatitis B in the Chinese population after vaccination. Computers in Biology and Medicine 2013; 43(9): 1167 doi: 10.1016/j.compbiomed.2013.05.021
|
3 |
Wenjing Zai, Kongying Hu, Jianyu Ye, Jiahui Ding, Chao Huang, Yaming Li, Zhong Fang, Min Wu, Cong Wang, Jieliang Chen, Zhenghong Yuan, Leiliang Zhang, Mengji Lu. Long-Term Hepatitis B Virus Infection Induces Cytopathic Effects in Primary Human Hepatocytes, and Can Be Partially Reversed by Antiviral Therapy. Microbiology Spectrum 2022; 10(1) doi: 10.1128/spectrum.01328-21
|
4 |
Robert G. Gish, Man-Fung Yuen, Henry Lik Yuen Chan, Bruce D. Given, Ching-Lung Lai, Stephen A. Locarnini, Johnson Y.N. Lau, Christine I. Wooddell, Thomas Schluep, David L. Lewis. Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent. Antiviral Research 2015; 121: 97 doi: 10.1016/j.antiviral.2015.06.019
|
5 |
Q Zheng, Y Y Zhu, J Chen, Y B Ye, J Y Li, Y R Liu, M L Hu, Y C Zheng, J J Jiang. Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection. Clinical and Experimental Immunology 2015; 180(3): 499 doi: 10.1111/cei.12597
|
6 |
Xiaojuan Wu, Zhenzhen Su, Bei Cai, Lin Yan, Yamei Li, Weihua Feng, Lanlan Wang. Increased Circulating Follicular Regulatory T-Like Cells May Play a Critical Role in Chronic Hepatitis B Virus Infection and Disease Progression. Viral Immunology 2018; 31(5): 379 doi: 10.1089/vim.2017.0171
|
7 |
Jianqin He, Guanjing Lang, Shiping Ding, Lanjuan Li, Bernhard Ryffel. Pathological Role of Interleukin-17 in Poly I:C-Induced Hepatitis. PLoS ONE 2013; 8(9): e73909 doi: 10.1371/journal.pone.0073909
|
8 |
Yong-Yuan Zhang, Ke-Qin Hu. Rethinking the pathogenesis of hepatitis B virus (HBV) infection. Journal of Medical Virology 2015; 87(12): 1989 doi: 10.1002/jmv.24270
|
9 |
Dimpu Gogoi, Biswajyoti Borkakoty, Dipankar Biswas, Jagadish Mahanta. Activation and Exhaustion of Adaptive Immune Cells in Hepatitis B Infection. Viral Immunology 2015; 28(7): 348 doi: 10.1089/vim.2014.0115
|
10 |
Kittiyod Poovorawan, Pisit Tangkijvanich, Chintana Chirathaworn, Naruemon Wisedopas, Sombat Treeprasertsuk, Piyawat Komolmit, Yong Poovorawan. Circulating Cytokines and Histological Liver Damage in Chronic Hepatitis B Infection. Hepatitis Research and Treatment 2013; 2013: 1 doi: 10.1155/2013/757246
|
11 |
XiaoLi Lou, YanQiang Hou, DongYu Liang. Effects of hepatitis B virus X protein on human T cell cytokines. Canadian Journal of Microbiology 2013; 59(9): 620 doi: 10.1139/cjm-2013-0259
|
12 |
Irina P Balmasova, Nikolay D Yushchuk, Ospan A Mynbaev, Nageswara R Alla, Elena S Malova, Zhongjie Shi, Chang-Lu Gao. Immunopathogenesis of chronic hepatitis B. World Journal of Gastroenterology 2014; 20(39): 14156-14171 doi: 10.3748/wjg.v20.i39.14156
|
13 |
Ekaterina A. Zaytseva, Larisa L. Popova, Dmitry Yu. Konstantinov. The use of Ingaron® in the treatment of chronic viral hepatitis B. Aspirantskiy Vestnik Povolzhiya 2020; 20(5-6): 63 doi: 10.17816/2072-2354.2020.20.3.63-67
|
14 |
Yadira Lobaina, Marie-Louise Michel. Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trials. Vaccine 2017; 35(18): 2308 doi: 10.1016/j.vaccine.2017.03.049
|
15 |
Wen-Lung Ma, Hsueh-Chou Lai, Shuyuan Yeh, Xiujun Cai, Chawnshang Chang. Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis. Endocrine-Related Cancer 2014; 21(3): R165 doi: 10.1530/ERC-13-0283
|
16 |
Qunying Han, Cuiling Yang, Na Li, Fang Li, Jiao Sang, Yi Lv, Wenxuan Zhao, Chunyan Li, Zhengwen Liu. Association of genetic variation in B-cell activating factor with chronic hepatitis B virus infection. Immunology Letters 2017; 188: 53 doi: 10.1016/j.imlet.2017.06.005
|
17 |
Zhongji Meng, Yonghong Zhang, Zhiqiang Wei, Ping Liu, Jian Kang, Yinhua Zhang, Deqiang Ma, Changzheng Ke, Yue Chen, Jie Luo, Zuojiong Gong. High serum resistin associates with intrahepatic inflammation and necrosis: an index of disease severity for patients with chronic HBV infection. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-016-0558-5
|
18 |
Weihua Cao, Minghui Li, Lu Zhang, Yao Lu, Shuling Wu, Ge Shen, Min Chang, Ruyu Liu, Yuanjiao Gao, Hongxiao Hao, Leiping Hu, Wei Yi, Calvin Q. Pan, Yao Xie, Udayan Apte. The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated‐Interferon versus Entecavir Therapy. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/2178143
|
19 |
Lu Sun, Yu Zhang, Bao Zhao, Mengmeng Deng, Jun Liu, Xin Li, Junwei Hou, Mingming Gui, Shuijun Zhang, Xiaodong Li, George F. Gao, Songdong Meng. A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes. Protein & Cell 2014; 5(4): 317 doi: 10.1007/s13238-014-0041-4
|
20 |
Xuefen Li, Yiyin Wang, Yu Chen. Cellular immune response in patients with chronic hepatitis B virus infection. Microbial Pathogenesis 2014; 74: 59 doi: 10.1016/j.micpath.2014.07.010
|
21 |
Jia Fu, Dan Guo, Dandan Gao, Wenxiang Huang, Ziqiong Li, Bei Jia. Clinical analysis of patients suffering from chronic hepatitis B superinfected with other hepadnaviruses. Journal of Medical Virology 2016; 88(6): 1003 doi: 10.1002/jmv.24417
|
22 |
Wei-Hua Cao, Ming-Hui Li, Calvin Q. Pan, Yao Lu, Lu Zhang, Chong-Ping Ran, Shu-Ling Wu, Wen-Hao Hua, Shun-Ai Liu, Ge Shen, Min Chang, Ru-Yu Liu, Hong-Xiao Hao, Lei-Ping Hu, Yao Xie. Quantitation of Plasmacytoid Dendritic Cells in Chronic Hepatitis B Patients with HBeAg Positivity During PEG-IFN and Entecavir Therapy. Journal of Interferon & Cytokine Research 2018; 38(5): 197 doi: 10.1089/jir.2018.0014
|
23 |
Jean Publicover, Anuj Gaggar, Jillian M. Jespersen, Ugur Halac, Audra J. Johnson, Amanda Goodsell, Lia Avanesyan, Stephen L. Nishimura, Meghan Holdorf, Keith G. Mansfield, Joyce Bousquet Judge, Arya Koshti, Michael Croft, Adil E. Wakil, Philip Rosenthal, Eric Pai, Stewart Cooper, Jody L. Baron. An OX40/OX40L interaction directs successful immunity to hepatitis B virus. Science Translational Medicine 2018; 10(433) doi: 10.1126/scitranslmed.aah5766
|
24 |
Dimpu Gogoi, Biswajyoti Borkakoty, Dipankar Biswas, Kaushal Yadav, Vainav Patel. Characteristics of Circulatory γδ T cells in Patients with Symptomatic Chronic Hepatitis B Infection. Viral Immunology 2021; 34(7): 483 doi: 10.1089/vim.2020.0314
|
25 |
Jinhong Chang, Fang Guo, Xuesen Zhao, Ju-Tao Guo. Therapeutic strategies for a functional cure of chronic hepatitis B virus infection. Acta Pharmaceutica Sinica B 2014; 4(4): 248 doi: 10.1016/j.apsb.2014.05.002
|
26 |
Sirio Fiorino, Maria Letizia Bacchi-Reggiani, Paolo Leandri, Elisabetta Loggi, Pietro Andreone. Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis: A systematic review and meta-analysis. World Journal of Hepatology 2017; 9(6): 333-342 doi: 10.4254/wjh.v9.i6.333
|
27 |
Murali Ganesan, Vjaceslav M. Krutik, Edward Makarov, Saumi Mathews, Kusum K. Kharbanda, Larisa Y. Poluektova, Carol A Casey, Natalia A. Osna. Acetaldehyde suppresses the display of HBV-MHC class I complexes on HBV-expressing hepatocytes. American Journal of Physiology-Gastrointestinal and Liver Physiology 2019; 317(2): G127 doi: 10.1152/ajpgi.00064.2019
|
28 |
Litao Zheng. Analysis of hepatocellular carcinoma associated with hepatitis B virus. Journal of Cellular and Molecular Medicine 2023; 27(16): 2271 doi: 10.1111/jcmm.17867
|
29 |
Yu Zhang, Yan Wu, Mengmeng Deng, Dongping Xu, Xiaodong Li, Zhihui Xu, Jun Hu, Han Zhang, Kefang Liu, Yingze Zhao, Feng Gao, Shengli Bi, George F. Gao, Jingmin Zhao, William J. Liu, Songdong Meng, J.-H. James Ou.
CD8
+
T-Cell Response-Associated Evolution of Hepatitis B Virus Core Protein and Disease Progress
. Journal of Virology 2018; 92(17) doi: 10.1128/JVI.02120-17
|
30 |
Kazuto Tajiri, Yukihiro Shimizu. New horizon for radical cure of chronic hepatitis B virus infection. World Journal of Hepatology 2016; 8(21): 863-873 doi: 10.4254/wjh.v8.i21.863
|
31 |
Wanzhou Zhao, Conghao Tan, Xi Yu, Ruihe Yu, Qibing Mei, Yun Cheng. A 7-Amino Acid Peptide Mimic from Hepatitis C Virus Hypervariable Region 1 Inhibits Mouse Lung Th9 Cell Differentiation by Blocking CD81 Signaling during Allergic Lung Inflammation. Journal of Immunology Research 2020; 2020: 1 doi: 10.1155/2020/4184380
|
32 |
Zhen-Hua Zhang, Chun-Chen Wu, Xin-Wen Chen, Xu Li, Jun Li, Meng-Ji Lu. Genetic variation of hepatitis B virus and its significance for pathogenesis. World Journal of Gastroenterology 2016; 22(1): 126-144 doi: 10.3748/wjg.v22.i1.126
|
33 |
Yang Zhang, Yi-Tong Wang, Jian-Xing Luo, Xiao-Yu Hu, Fang Yang, Wu Lin, Xiao Liang, Bing-Jie Zhao, Song Zhang, Yuan-Yuan Chen. Effect of WSP, a Chinese Herbal Formula, on Th17/Treg Ratio and HBeAg Seroconversion in Telbivudine-Treated HBeAg-Positive Chronic Hepatitis B Patients with High Baseline ALT Levels (20–30 Times the ULN). Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/7260369
|
34 |
Lu Zong, Hui Peng, Cheng Sun, Fenglei Li, Meijuan Zheng, Yongyan Chen, Haiming Wei, Rui Sun, Zhigang Tian. Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice. Nature Communications 2019; 10(1) doi: 10.1038/s41467-018-08096-8
|